Seikagaku (TSE:4548) Common Stock : 円3,840 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Seikagaku Common Stock?

Seikagaku's quarterly common stock stayed the same from Jun. 2023 (円3,840 Mil) to Sep. 2023 (円3,840 Mil) and stayed the same from Sep. 2023 (円3,840 Mil) to Dec. 2023 (円3,840 Mil).

Seikagaku's annual common stock stayed the same from Mar. 2021 (円3,840 Mil) to Mar. 2022 (円3,840 Mil) and stayed the same from Mar. 2022 (円3,840 Mil) to Mar. 2023 (円3,840 Mil).

Seikagaku Common Stock Historical Data

The historical data trend for Seikagaku's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seikagaku Common Stock Chart

Seikagaku Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Common Stock

Get a 7-Day Free Trial

3,840.00

Seikagaku Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															3,840.00	3,840.00	3,840.00	3,840.00	3,840.00

Seikagaku Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Seikagaku (TSE:4548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Seikagaku Corp (TSE:4548) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005

Website

http://www.seikagaku.co.jp

Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

Seikagaku (TSE:4548) Headlines

No Headlines